Posted by Michael Wonder on 22 Sep 2016
CADTH calls for patient input on a resubmission from NovoNordisk for Victoza (liraglutide)
21 September 2016 - CADTH is calling for patient input on a resubmission from Novo Nordisk for Victoza (liraglutide).
CADTH rejected Novo Nordisk's initial submission for Victoza back in 2011 due to uncertain clinical benefit.
Read detalls on the pending resubmission for Victoza
Read CADTH's 2011 do not list recommendation for Victoza
